- Planet of the AAVs: The Spinal Cord Injury Episode2021 | Second Faculty of Medicine
- Pathophysiology of ANCA-associated vasculitis2020 | First Faculty of Medicine
- Alemtuzumab by refracting ANCA-associated vasculiltis2012 | First Faculty of Medicine
- AAV ablates neurogenesis in the adult murine hippocampus2021 | Second Faculty of Medicine
- Treatment of patients with ANCA - associated vasculitis and systemic lupus erythemadosus by mycophenolate mofetil - a retrospective studyPublication without faculty affiliation
- Exposure to Silica and Risk of ANCA-Associated Vasculitis2006 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Life-Long Correction of Hyperbilirubinemia with a Neonatal Liver-Specific AAV-Mediated Gene Transfer in a Lethal Mouse Model of Crigler-Najjar Syndrome2014 | First Faculty of Medicine
- Intracellular Cytokine Production in ANCA-associated Vasculitis: Low Levels of Interleukin-10 in Remission Are Associated with a Higher Relapse Rate in the Long-term Follow-up2009 | First Faculty of Medicine
- Sustained Reduction of Hyperbilirubinemia in Gunn Rats After Adeno-Associated Virus-Mediated Gene Transfer of Bilirubin UDP-Glucuronosyltransferase Isozyme 1A1 to Skeletal Muscle2012 | First Faculty of Medicine
- News in the treatment of ANCA-associated vasculitides2013 | First Faculty of Medicine
- Analysis of microRNAs in Small Urinary Extracellular Vesicles and Their Potential Roles in Pathogenesis of Renal ANCA-Associated Vasculitis2022 | First Faculty of Medicine
- Novel trends in monitoring and therapy of ANCA associated vasculitides2018 | First Faculty of Medicine
- Efficiency of rituximab in ANCA-associated vasulitis in comparison with standard induction and maintanance treatment2013 | First Faculty of Medicine
- Pitfalls of diagnosis of ANCA-associated vasculitis - case report2020 | First Faculty of Medicine, Central Library of Charles University
- Advantages of anti-myeloperoxidase and anti-proteinase-3 antibodies detection by chemiluminescence method in patients with ANCA-associated vasculitis2018 | First Faculty of Medicine
- Avacopan - nová možnost v léčbě ANCA asociované vaskulitidy?2021 | First Faculty of Medicine
- Má mykofenolát mofetil místo v indukční léčbě ANCA asociované vaskulitidy?2019 | First Faculty of Medicine
- Nová klasifikační kritéria pro ANCA asociované vaskulitidy2022 | First Faculty of Medicine
- Nová klasifikační kritéria pro vaskulitidy velkých cév2022 | First Faculty of Medicine
- Plazmaferéza v léčbě ANCA asociované vaskulitidy: ano, či ne?2022 | First Faculty of Medicine
- Immunohistochemical characterization of bipolar cells in four distantly related avian species2023 | Faculty of Science
- Moderator's view: Should all patients with ANCA-associated vasculitis be primarily treated with rituximab?2015 | First Faculty of Medicine
- Increased Levels of Soluble ST2 in Patients with Active Newly Diagnosed ANCA-Associated Vasculitis2015 | First Faculty of Medicine
- Avacopan in the treatment of ANCA-associated vasculitis2018 | First Faculty of Medicine
- Conventional induction and maintenance treatment of Antineutrophil cytoplasmic antibodies-associated vasculitis - still of value for our patients?2015 | First Faculty of Medicine
- Renal transplantation in anti-neutrophil cytoplasmic antibody-associated vasculitis2015 | First Faculty of Medicine
- Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry2015 | First Faculty of Medicine
- Complement Inhibition in ANCA-Associated Vasculitis2022 | First Faculty of Medicine
- Matrix Metalloproteinases and Their Tissue Inhibitors: an Evaluation of Novel Biomarkers in ANCA-Associated Vasculitis2019 | First Faculty of Medicine
- ANCA-Associated Renal Vasculitis - An Update2013 | First Faculty of Medicine